secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001104659-23-085172
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharmaceuticals appoints PKF Mueller as new independent auditor for FY2022
--------------------------------------------------------------------------------

- Audit Committee approved PKF Mueller as new independent registered public accounting firm on July 21, 2023.
- PKF Mueller formally engaged on July 27, 2023 to audit fiscal year ending December 31, 2022.
- No consultations with PKF Mueller on accounting principles or audit opinions prior to appointment.
- No reportable disagreements or reportable events with predecessor auditor exist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923085172/0001104659-23-085172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923085172/tm2322281d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-085172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer